Elevated levels of Notch-1, 3 and their ligand Jagged 1–4 expressions were found to be associated with tumor progression and predicted poor prognosis in NSCLC, suggesting a promising biomarker for NSCLC [62],[63]. This evidence concerns the gene JAG1 and non-small cell lung carcinoma.